Gene · 8915
Papers2,643
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 2,643
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| MALT lymphoma of the sublingual gland: A case report with current overview of diagnostic and therapeutic strategies. | Clin Case Rep | 2022 | 36237943 | PubTator, text mining | PubMed |
| Bacterial Involvement in Progression and Metastasis of Adenocarcinoma of the Stomach. | Cancers (Basel) | 2022 | 36230809 | PubTator, text mining | PubMed |
| Spontaneous rupture and upper gastrointestinal bleeding of solid pseudopapillary neoplasm of the pancreas. | J Surg Case Rep | 2022 | 36226134 | PubTator, text mining | PubMed |
| Association between CARD14 gene polymorphisms and psoriasis vulgaris in Hainan Han population based on exon sequencing: A case-control study. | Medicine (Baltimore) | 2022 | 36221432 | PubTator, text mining | PubMed |
| Lessons to cancer from studies of leukemia and hematopoiesis. | Front Cell Dev Biol | 2022 | 36204679 | PubTator, text mining | PubMed |
| A novel CARD11 germline mutation in a Chinese patient of B cell expansion with NF-κB and T cell anergy (BENTA) and literature review. | Front Immunol | 2022 | 36203613 | PubTator, text mining | PubMed |
| Role of K63-linked ubiquitination in cancer. | Cell Death Discov | 2022 | 36202787 | PubTator, text mining | PubMed |
| Regulation of cGAS/STING signaling and corresponding immune escape strategies of viruses. | Front Cell Infect Microbiol | 2022 | 36189363 | PubTator, text mining | PubMed |
| BTK kinase activity is dispensable for the survival of diffuse large B-cell lymphoma. | J Biol Chem | 2022 | 36183831 | PubTator, text mining | PubMed |
| BTK inhibitors in the treatment of hematological malignancies and inflammatory diseases: mechanisms and clinical studies. | J Hematol Oncol | 2022 | 36183125 | PubTator, text mining | PubMed |
| Durable response to olaparib combined low-dose cisplatin in advanced hepatocellular carcinoma with FANCA mutation: A case report. | Medicine (Baltimore) | 2022 | 36181052 | PubTator, text mining | PubMed |
| Toll-like receptor 2 signaling pathway activation contributes to a highly efficient inflammatory response in Japanese encephalitis virus-infected mouse microglial cells by proteomics. | Front Microbiol | 2022 | 36171749 | PubTator, text mining | PubMed |
| Screening for differentially expressed microRNAs in BALF and blood samples of infected COVID-19 ARDS patients by small RNA deep sequencing. | J Clin Lab Anal | 2022 | 36166345 | PubTator, text mining | PubMed |
| Immunogenetics associated with severe coccidioidomycosis. | JCI Insight | 2022 | 36166305 | PubTator, text mining | PubMed |
| The impact of selected food additives on the gastrointestinal tract in the example of nonspecific inflammatory bowel diseases. | Arch Med Sci | 2022 | 36160334 | PubTator, text mining | PubMed |
| Proteomic analysis of arylamine N-acetyltransferase 1 knockout breast cancer cells: Implications in immune evasion and mitochondrial biogenesis. | Toxicol Rep | 2022 | 36158865 | PubTator, text mining | PubMed |
| Occurrence of MYD88L265P and CD79B mutations in diffuse large b cell lymphoma with bone marrow infiltration: A case report. | World J Clin Cases | 2022 | 36158496 | PubTator, text mining | PubMed |
| Deregulated miRNA clusters in ovarian cancer: Imperative implications in personalized medicine. | Genes Dis | 2022 | 36157483 | PubTator, text mining | PubMed |
| A Stk4-Foxp3-NF-κB p65 transcriptional complex promotes Treg cell activation and homeostasis. | Sci Immunol | 2022 | 36149942 | PubTator, text mining | PubMed |
| Integrating knowledge of protein sequence with protein function for the prediction and validation of new MALT1 substrates. | Comput Struct Biotechnol J | 2022 | 36147669 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8915/papers?page=19